News Conference News TCT 2012 Presentations Examine Multiple Facets of Antiplatelet Agents October 24, 2012
News Conference News TCT 2012 Flexibility with Future Reform, Contract Negotiations Key to Career Success October 24, 2012
News Industry News PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy October 24, 2012
News Industry News Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2) October 24, 2012
News Conference News TCT 2012 Maintaining Successful Practice Depends on Changing Old Habits, Embracing CV Service Lines October 24, 2012
News Conference News TCT 2012 REOPEN-AMI: Addition of Adenosine to Thrombus Aspiration Enhances PCI Outcomes October 24, 2012
News Industry News Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease October 24, 2012
News Conference News TCT 2012 DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS October 24, 2012
News Conference News TCT 2012 FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy October 24, 2012
News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012